Sanofi and Regeneron Pharmaceuticals Inc.’s experimental treatment alirocumab lowered cholesterol three times more than Merck & Co.’s Zetia in the first late- stage study of a drug that may garner $3 billion sales annually.
Sanofi Chief Executive Officer Chris Viehbacher said the French drugmaker will return to earnings growth in the fourth quarter after the loss of patent protection on nine drugs in the past three years eroded profit.
When Chris Viehbacher , the chief executive of Paris-based drugmaker Sanofi-Aventis SA , was trying to keep details of his unsolicited bid last year for Genzyme Corp. under wraps, he couldn’t resist drawing on his beloved Bordeaux.
Sanofi Chief Executive Officer Chris Viehbacher said a proposal by the European Medicines Agency to disclose more clinical-trial data threatens to undermine the competitiveness of the region’s drug industry.
Workers at Sanofi had a message for politicians at protests in Paris this month: Job cuts by the nation’s biggest drugmaker are crushing morale among researchers and hurting the company’s ability to develop new products.
Sanofi, whose vaccines have all but eradicated polio, recently flew journalists from around the globe to a sparkling new factory in France to tout its next big project -- the world’s first vaccine for dengue.